Wells Fargo & Company Stryker Corp Call Options Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$315.94 - $371.96 $473,910 - $557,940	1,500 Added 15.0%	11,500 $4.15 Million
Q2 2024 Aug 13, 2024	BUY	$324.3 - $354.67 $3.24 Million - $3.55 Million	10,000 New	10,000 $3.4 Million
Q3 2023 Nov 13, 2023	SELL	$266.54 - $302.43 $479,772 - $544,374	-1,800 Reduced 14.29%	10,800 $2.95 Million
Q1 2023 May 12, 2023	BUY	$246.13 - $285.47 $3.1 Million - $3.6 Million	12,600 New	12,600 $3.6 Million

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $137B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.